-
Malaysia's JDT claims unbeaten run world record
-
At least 2 teens seriously wounded in sword attack at Swedish school
-
Bolivian economy minister fired after Congress vote
-
Popular forest near Paris to reopen after wildfire
-
Russell roars to Dutch GP sprint pole, Antonelli fifth
-
UN holds second informal poll of secretary-general candidates
-
Russell takes pole for Dutch GP sprint
-
Shakhtar Donetsk to play Champions League home games at Chelsea
-
England start life after Bazball with rout of Pakistan
-
Arsenal sign Villa centre-back Konsa as champions bolster defence
-
'Duck run' pest control catching on in S.Africa's winelands
-
The 'hedgehogs' leading Poland's defences on Russian border
-
UK, Canada, Australia slam Israel ending probe into aid worker killings
-
England thrash Pakistan by an innings and 103 runs in first Test
-
Spurs spending spree vital to raise standards: De Zerbi
-
Fury says Joshua fight 'doesn't look like it's going to happen'
-
US, Canada try to wrap up trade deal before latest Trump deadline
-
Argentina's Paredes suspended 10 matches by FIFA for World Cup fight
-
World No.1 Sinner withdraws from US Open with knee injury
-
Watkins and Martinez could join Villa exodus says Emery
-
Judge allows UK rugby brain injury court case to continue to trial
-
UK court orders Prince Harry, others to pay Daily Mail £9.5mn
-
Trump announces temporary tariff relief on ground beef imports
-
Aligned Launches $ALIGN, the Native Token of Its Full Ethereum Stack
-
Pope to visit San Marino, address Italian political event
-
Bitcoin jumps, stocks bounce as traders weigh US Treasury action
-
All Blacks just as good as Springboks, says captain Savea
-
Man City boss Maresca hit with Doku injury blow
-
Romania holding suspected 'low-level agent' after pistols found near Berlin: Germany
-
Iraola wants to sign wingers to boost Liverpool's attacking options
-
UK forecasts 'biggest' El Nino will smash records, spark hottest year
-
Maresca needs time to succeed after 'big changes' at Man City
-
Cyclist Alaphilippe attracts tributes as reports say he has quit
-
Meghan faces difficult return to the UK
-
Top-ranked An, holder Yamaguchi reach badminton worlds semi-finals
-
Archer double strengthens England's grip on first Test against Pakistan
-
Iran president says time to end war while in position of strength
-
MEXC Lists Ondo Tokenized Stock Moderna (MRNAON), Expanding Access to U.S. Biotech Exposure
-
Antonelli fastest in sole Dutch GP practice session
-
Japan axes Netflix collaboration after outcry over dating show
-
2,500 dead and rising -- UN says DR Congo Ebola outbreak 'growing exponentially'
-
Stocks tread cautiously as traders weigh US Treasury action
-
England all out for 409, lead Pakistan by 238 runs in 1st Test
-
STARTRADER Launches XAUUSD247, Extending Gold CFD Access Across the Full Week
-
Premier League returns with Arsenal eyeing title dynasty
-
Spurs agree deal to sign Man City's Savinho: reports
-
Bayern knew about Musiala's condition 'a long time ago' says Kompany
-
US-sanctioned ICC head warns against 'demise of international rule of law'
-
Ex-Pakistan PM Khan taken back to jail after hospital checks
-
Top India court orders new steps to protect threatened elephants
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
HACKENSACK, NJ / ACCESS Newswire / July 20, 2026 / Champions Oncology, Inc. (NASDAQ:CSBR), a global leader in clinically relevant oncology research models and translational solutions, will report its financial and operational results for the quarter and year ended April 30, 2026, on Monday, July 27, 2026, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. ET (1:30 P.M. PT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 347142. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 54320, or by accessing the investors section of the company's website within 72 hours.
About Champions Oncology, Inc.
Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions and innovative data platforms to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.
Media Inquiries:
Gavin Cooper
Vice President, Global Marketing
[email protected]
Website: https://www.championsoncology.com/
Facebook: https://www.facebook.com/championsoncology/
LinkedIn: https://www.linkedin.com/company/champions-oncology-inc-/
Twitter: @ChampionsOncol1
Instagram: https://www.instagram.com/championsoncology/
SOURCE: Champions Oncology, Inc.
View the original press release on ACCESS Newswire
Ch.Campbell--AT